deoxyglucose has been researched along with B-Cell Chronic Lymphocytic Leukemia in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Branca, JA; Chow, KH; Costa, M; Hasham, MG; Labrie, NJ; Mills, KD; Perkins, BRA; Roopenian, DC; Rosales, C; Sproule, TJ; Stafford, G; Wilson, JJ; Wolf, EE | 1 |
Arimizu, N; Imazeki, K; Itami, J; Kuyama, J; Maruno, H; Minoshima, S; Okada, J; Uno, K; Yoshikawa, K | 1 |
2 other study(ies) available for deoxyglucose and B-Cell Chronic Lymphocytic Leukemia
Article | Year |
---|---|
Enhancing the efficacy of glycolytic blockade in cancer cells
Topics: 4,4'-Diisothiocyanostilbene-2,2'-Disulfonic Acid; Animals; Antineoplastic Combined Chemotherapy Protocols; Cell Line, Tumor; Deoxyglucose; Drug Synergism; Female; Glycolysis; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Lung Neoplasms; Mice; Mice, Inbred C57BL; Mice, Inbred NOD; Neoplasms; Rad51 Recombinase; Xenograft Model Antitumor Assays | 2019 |
The use of FDG-PET in the detection and management of malignant lymphoma: correlation of uptake with prognosis.
Topics: Adult; Aged; Aged, 80 and over; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoma, Follicular; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prognosis; Tomography, Emission-Computed | 1991 |